BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 8423042)

  • 1. Effect of dipyridamole on kidney function in cirrhosis.
    Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J
    Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
    Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
    Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal.
    Sansoè G; Silvano S; Mengozzi G; Smedile A; Todros L; Baronio M; Bonardi L; Rizzetto M
    Am J Gastroenterol; 2002 Sep; 97(9):2383-90. PubMed ID: 12358261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal hemodynamics and the renin-angiotensin system in cirrhosis.
    Aliaga L; Zozaya JM; Quiroga J; Richter JA; Prieto J
    Rev Esp Fisiol; 1989; 45 Suppl():371-5. PubMed ID: 2701770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
    Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.
    Thiesson HC; Skøtt O; Jespersen B; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2003 Jan; 98(1):180-6. PubMed ID: 12526955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of peritoneovenous shunting in unravelling the pathogenesis of ascites in cirrhosis.
    Blendis LM
    Isr J Med Sci; 1986 Feb; 22(2):78-80. PubMed ID: 3512475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity.
    Wong F; Logan A; Blendis L
    Hepatology; 1996 Mar; 23(3):414-22. PubMed ID: 8617419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of renal effects of fish oil administration in patients with advanced cirrhosis and impaired glomerular filtration.
    Badalamenti S; Salerno F; Salmeron JM; Lorenzano E; Rimola A; Ginés P; Jimenez W; Graziani G; Arroyo V; Rodes J; Ponticelli C
    Hepatology; 1997 Feb; 25(2):313-6. PubMed ID: 9021940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term administration of isosorbide-5-mononitrate does not impair renal function in cirrhotic patients.
    Salerno F; Borroni G; Lorenzano E; Solenghi D; Cazzaniga M; Bissoli F; Ceriani R; deFranchis R
    Hepatology; 1996 May; 23(5):1135-40. PubMed ID: 8621145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cerebrovascular resistance in cirrhotic patients with ascites.
    Guevara M; Bru C; Ginès P; Fernández-Esparrach G; Sort P; Bataller R; Jiménez W; Arroyo V; Rodés
    Hepatology; 1998 Jul; 28(1):39-44. PubMed ID: 9657094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal and systemic hemodynamics and humoral factors in cirrhosis with and without ascites.
    Hayes PC; Cumming AD; Craig KJ; Watson M; Bouchier IA
    Am J Gastroenterol; 1992 Oct; 87(10):1433-8. PubMed ID: 1415100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of ascites in cirrhosis and portal hypertension.
    Heneghan MA; Harrison PM
    Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of beta adrenergic blocking drugs on the renin-aldosterone system, sodium excretion, and renal hemodynamics in cirrhosis with ascites.
    Wilkinson SP; Bernardi M; Smith IK; Jowett TP; Slater JD; Williams R
    Gastroenterology; 1977 Oct; 73(4 Pt 1):659-63. PubMed ID: 19338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.